COVID-19 vaccine
Moderna have published antibody persistence data out to six months following the second dose of its COVID-19 vaccine (mRNA-1273) in The New England Journal of Medicine this week.
The data analysed was from 33 healthy adult participants in the NIH-led Phase I study of Moderna’s COVID-19 vaccine, taken six months after a second dose was administered.
